Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
McKesson
Moodys
Harvard Business School

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Norketamine


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Norketamine?

Norketamine is an investigational drug.

There have been 9 clinical trials for Norketamine. The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2018.

The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Pain, Postoperative. The leading clinical trial sponsors are Arkansas Children's Hospital Research Institute, University of Texas Southwestern Medical Center, and Tel-Aviv Sourasky Medical Center.

There are forty-five US patents protecting this investigational drug and three hundred and fifty-three international patents.

Recent Clinical Trials for Norketamine
TitleSponsorPhase
Phase 1 Evaluation of (2R,6R)-HydroxynorketamineNational Institute of Mental Health (NIMH)Phase 1
The Role of HNKs in the Antidepressant Effect of KetamineColumbia UniversityPhase 1
Acute Pain Management in Patients on Opioid Replacement TherapyUniversity of California, San FranciscoPhase 1

See all Norketamine clinical trials

Clinical Trial Summary for Norketamine

Top disease conditions for Norketamine
Top clinical trial sponsors for Norketamine

See all Norketamine clinical trials

US Patents for Norketamine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Norketamine ⤷  Sign up for a Free Trial Rapid evaporative ionisation mass spectrometry ("REIMS") and desorption electrospray ionisation mass spectrometry ("DESI-MS") analysis of swabs and biopsy samples MICROMASS UK LIMITED (Wilmslow, GB) ⤷  Sign up for a Free Trial
Norketamine ⤷  Sign up for a Free Trial Transmucosal ketamine delivery composition Pharmaceutical Productions, Inc. (Miami Springs, FL) ⤷  Sign up for a Free Trial
Norketamine ⤷  Sign up for a Free Trial Ketamine derivatives Auckland Uniservices Limited (Auckland, NZ) ⤷  Sign up for a Free Trial
Norketamine ⤷  Sign up for a Free Trial Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods Amorsa Therapeutics, Inc. (Littleton, MA) ⤷  Sign up for a Free Trial
Norketamine ⤷  Sign up for a Free Trial Assay for methoxetamine Randox Laboratories Ltd. (GB) ⤷  Sign up for a Free Trial
Norketamine ⤷  Sign up for a Free Trial Rapid and sensitive method of forensic toxicology in post-mortem subjects using oral fluid testing ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Norketamine

Drugname Country Document Number Estimated Expiration Related US Patent
Norketamine Canada CA2977900 2035-03-06 ⤷  Sign up for a Free Trial
Norketamine Canada CA2977906 2035-03-06 ⤷  Sign up for a Free Trial
Norketamine Canada CA2978042 2035-03-06 ⤷  Sign up for a Free Trial
Norketamine Canada CA2978048 2035-03-06 ⤷  Sign up for a Free Trial
Norketamine Canada CA2978165 2035-03-06 ⤷  Sign up for a Free Trial
Norketamine Canada CA2978166 2035-03-06 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
McKesson
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.